Dhruvalkumar Patel takes 10.01% of Rekvina Laboratories via open offer
What's the deal? Dhruvalkumar Patel has acquired a 10.01% stake in Rekvina Laboratories LtdDealroom has a profile for this one. Try Dealroom →, or 11,12,562 equity shares. The purchase combined a preferential allotment of 2,22,562 shares on August 12, 2026, with an open offer for 8,90,000 shares on August 13, 2026.
Why now? The preferential allotment stems from a Share Exchange and Purchase Agreement dated March 16, 2026, pointing to a planned change in ownership. The filing follows SEBI's takeover regulations.
What changes now? Rekvina's equity capital has grown from US$408.8K, or 60,28,000 shares, to US$755.1K, or 1,11,15,750 shares, reflecting the new shares issued and acquired.
What could go wrong? The arrival of a major new shareholder could reshape management or strategic direction — shifts existing shareholders will want to watch.
The signal: A negotiated share agreement paired with an open offer marks a deliberate ownership shift at Rekvina, setting up Patel as a shareholder with the weight to influence the company's next moves.
Read more: WhalesBook
Image credit: foteih
